During his talk, Ken Lau Lab is discussing the hallmarks of #precancer , including age-related genetic alterations. Read more in Cancer Discovery: aacrjournals.org/cancerdiscover… #SMC3B

Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer [Oct 18, 2023] Sarah Phillips Suehnholz et al. Cancer Discovery aacrjournals.org/cancerdiscover… OncoKB™ @sloan_kettering HT Anirban Maitra #PrecisionMedicine

Pan-cancer comparative and integrative analyses of driver alterations using Japanese and international genomic databases [Jan 26, 2024] Sara Horie Yuki Saito Keisuke Kataoka Laboratory（片岡 圭亮 研究室） et al. Cancer Discovery bit.ly/490njke #PrecisionMedicine #globonc 国立がん研究センター研究所 NCCRI Japan Official Account 国立がん研究センターがんゲノム情報管理センター（C-CAT）

During her presentation, Sheila Stewart is showing that senescent cancer-associated fibroblasts suppress Natural Killer cell activity and promote #BreastCancer progression in preclinical models. Read more in a recent Cancer Discovery study: aacrjournals.org/cancerdiscover… #SMC3B #BCSM

Now online in Cancer Discovery: A Next-Gen #BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in Patients w/BRAF-Mutant Cancers Using Pharmacokinetics-Informed Dose Escalation - by Rona Yaeger, S. Michael Rothenberg, et al. doi.org/10.1158/2159-8… Memorial Sloan Kettering Cancer Center Pfizer Oncology Medical

Great work by Doug Rubinson and colleagues, we enjoyed the reading and the writing of the In the Spotlight Cancer Discovery commentary. There’s still so much we can discover about RAS inhibition, exciting times!
shorturl.at/huKV2
shorturl.at/FILR6

#CorcoranLab #OnTheCover Mass General Cancer Center Cancer Discovery
aacrjournals.org/cancerdiscover…

The May issue of Cancer Discovery is now online! The cover features work by Doug Rubinson, Noritaka Tanaka, Andrew Aguirre, Ryan Corcoran et al. showing sotorasib is a pan-RAS G12C inhibitor - read that and much more here: aacrjournals.org/cancerdiscover…

Do read this 👇Cancer Discovery!

📢Big news! We have an opening on the Cancer Discovery team! If you've ever thought about making the switch to an editorial career, now's your chance - join us in Philadelphia or Boston! linkedin.com/jobs/view/3914…

Now online in Cancer Discovery: Molecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B Cell #Lymphoma - by Sean Corcoran, Daniel Hodson, Louis Staudt et al. doi.org/10.1158/2159-8… National Cancer Institute NCI Center for Cancer Research Cambridge Stem Cell Institute Cambridge University

Our paper is out Cancer Discovery! We found ways to improve Pola-V on-target efficacy and used Pola-V as a tool to study the B-Cell Receptor.

A collaborative effort between Louis Staudt and Dan Hodson through NIHOxCam National Cancer Institute Cambridge University by way of BU MD/PhD Program

aacrjournals.org/cancerdiscover…

Now online in Cancer Discovery: back-to-back papers from the labs of Sheila Stewart and David DeNardo WUSM on immunosuppression by senescent CAFs in breast and pancreatic cancers doi.org/10.1158/2159-8… doi.org/10.1158/2159-8… Jennifer Jiayu Ye Jad Belle #DevashishSen Washington U. Med Siteman Cancer Center

Congratulations to Bell and Yi on back to back Cancer Discovery papers. Go Sheila Stewart and Siteman Cancer Center
aacrjournals.org/cancerdiscover…

Just out from our friends at Cancer Discovery 🇺🇸
by Elsa Anagnostou & Victor Velculescu of Johns Hopkins University

Special commentary just out on pushing the boundaries of liquid biopsies for early precision intervention
OncoAlert 🇺🇸

Comprehensive overview of new Boundaries of #liquidbiopsy by Elsa Anagnostou and Victor Velculescu in Cancer Discovery
International Society of Liquid Biopsy
Elizabeth McKenna Tali Lev I-Mei (Emay) Siu

aacrjournals.org/cancerdiscover…

Pan-Cancer Efficacy of Vemurafenib in BRAFV600-Mutant Non-Melanoma Cancers [February 6, 2020] Vivek Subbiah, MD et al. Cancer Discovery ow.ly/lVue30qfGny AACR #PrecisionMedicine

Pushing the Boundaries of Liquid Biopsies for Early Precision Intervention ⁦Cancer Discovery⁩ aacrjournals.org/cancerdiscover…

Accelerating Drug Development Using Spatial Multi-omics ⁦Cancer Discovery⁩ aacrjournals.org/cancerdiscover…